Autodesk, Inc. | |||||||
Condensed Consolidated Statements of Cash Flows | |||||||
(In millions) | |||||||
|
|
|
| ||||
| Six Months Ended July 31, | ||||||
| 2020 |
| 2019 | ||||
| (Unaudited) | ||||||
Operating activities: |
|
|
| ||||
Net income | $ | 164.7 |
|
| $ | 16.0 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| ||||
Depreciation, amortization and accretion | 60.0 |
|
| 64.8 |
| ||
Stock-based compensation expense | 194.1 |
|
| 163.4 |
| ||
Deferred income taxes | 14.5 |
|
| 35.8 |
| ||
Restructuring and other exit costs, net | — |
|
| 0.4 |
| ||
Other | 36.0 |
|
| (4.2) |
| ||
Changes in operating assets and liabilities |
|
|
| ||||
Accounts receivable | 162.7 |
|
| 125.8 |
| ||
Prepaid expenses and other assets | (52.0) |
|
| 27.4 |
| ||
Accounts payable and other liabilities | (42.8) |
|
| (138.1) |
| ||
Deferred revenue | (130.0) |
|
| 158.3 |
| ||
Accrued income taxes | 11.3 |
|
| (9.1) |
| ||
Net cash provided by operating activities | 418.5 |
|
| 440.5 |
| ||
Investing activities: |
|
|
| ||||
Purchases of marketable securities | (17.0) |
|
| (19.9) |
| ||
Sales of marketable securities | — |
|
| 22.4 |
| ||
Maturities of marketable securities | 11.0 |
|
| 5.0 |
| ||
Capital expenditures | (46.7) |
|
| (29.5) |
| ||
Purchases of developed technologies | (4.8) |
|
| — |
| ||
Other investing activities | (54.3) |
|
| (10.5) |
| ||
Net cash used in investing activities | (111.8) |
|
| (32.5) |
| ||
Financing activities: |
|
|
| ||||
Proceeds from issuance of common stock, net of issuance costs | 58.5 |
|
| 49.7 |
| ||
Taxes paid related to net share settlement of equity awards | (39.6) |
|
| (31.2) |
| ||
Repurchases of common stock | (209.0) |
|
| (134.6) |
| ||
Repayment of debt | (450.0) |
|
| (250.0) |
| ||
Other financing activities | (2.5) |
|
| — |
| ||
Net cash used in financing activities | (642.6) |
|
| (366.1) |
| ||
Effect of exchange rate changes on cash and cash equivalents | 1.0 |
|
| (4.0) |
| ||
Net (decrease) increase in cash and cash equivalents | (334.9) |
|
| 37.9 |
| ||
Cash and cash equivalents at beginning of period | 1,774.7 |
|
| 886.0 |
| ||
Cash and cash equivalents at end of period | $ | 1,439.8 |
|
| $ | 923.9 |
|
|
|
|
| ||||
Supplemental cash flow disclosure: |
|
|
| ||||
Non-cash financing activities: |
|
|
| ||||
Fair value of common stock issued to settle liability-classified restricted stock units | $ | 28.7 |
|
| $ | — |
|